Biobohemia is a biotechnology company engaged in research and development of innovative proprietary products in the field of oncology, and have discovered a potentially non-toxic, selective and targeted approach for treating various forms of cancer.

Biobohemia's lead product, SANTAVACTM (Set of All Natural Target Antigens for Vaccination Against Cancer) is an antigen composition developed by proteomics and cell culture technology and intended for development of cancer vaccines against solid tumors.

About our company and technology

Biobohemia is a biotechnology company engaged in research and development of innovative proprietary products in the field of oncology, and have discovered a potentially non-toxic, selective and targeted approach for treating various forms of cancer.

Biobohemia's lead product, SANTAVACTM (Set of All Natural Target Antigens for Vaccination Against Cancer) is an antigen composition developed by proteomics and cell culture technology and intended for development of cancer vaccines against solid tumors.